Selected Grants
RofLumilast or Azithromycin to preveNt COPD Exacerbations (RELIANCE) - REIMBURSEABLE
ResearchPrincipal Investigator · Awarded by University of Illinois at Chicago · 2017 - 2027COPD Pulmonary Rehab GEMSSTAR Award
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025Snake in the Grass: Cardiovascular Outcome Risks After AECOPD (COBRA)
ResearchPrincipal Investigator · Awarded by American Lung Association · 2022 - 2024Phase 2 COPD
ResearchPrincipal Investigator · Awarded by Pfizer, Inc. · 2024 - 2024Phase 2 Asthma
ResearchPrincipal Investigator · Awarded by Pfizer, Inc. · 2024 - 2024Inspiration Point- A Digital Pulmonary Rehabilitation Tool for use with Self-Management Interventions
ResearchPrincipal Investigator · Awarded by Blue Marble Rehab Inc. · 2022 - 2023Identifying treatment outcomes and early predictors of failure in 600 hospitalized patients with acute exacerbation of COPD treated with non-invasive ventilation
ResearchPrincipal Investigator · Awarded by Chest Foundation · 2019 - 2020Fellowships, Gifts, and Supported Research
RofLumilast or Azithromycin to preveNt COPD Exacerbations (RELIANCE) ·
November 1, 2017
Awarded by: PCORI
External Relationships
- American Lung Association
- AstraZeneca
- Blue Marble Health
- COPDgene Study
- Chronic Obstructive Pulmonary Disease (COPD) Foundation
- GlaxoSmithKline
- Guidepoint Global, LLC
- Horizon CME/Pri-Med
- International Consulting Associates, Inc.
- National Institute of Aging
- Patient Centered Outcomes Research Institute
- The Lang Family COPD Research Fund
- Wellinks
- physician education resources llc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.